Adverse events associated with GLP1-receptor agonists treatment in diabetic patients with high cardiovascular risk: a meta-analysis
Anno:
2024
Background: GLP1-receptor agonists (GLP1-RA) have been associated with a reduction of cardiovascular (CV) outcomes in diabetic patients with high cardiovascular risk. However, these drugs have some adverse effects. The aim of this study was to assess the relative risk (RR) of adverse effects in patients with a high risk…